{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:40:52Z","timestamp":1792708852793,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mam.2026.101522","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:51:49Z","timestamp":1792569109000},"page":"101522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intermediate-half-life metabolites as systemic relay nodes in metabolic disease"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2767-2065","authenticated-orcid":false,"given":"Sang-Seop","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-4449","authenticated-orcid":false,"given":"Byung Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-6104","authenticated-orcid":false,"given":"Yung-Choon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/cpt.70103","article-title":"Quantitative approaches to accelerate MASH drug discovery and development","volume":"118","author":"Abouelhassan","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41746-024-01021-y","article-title":"Beyond the 510(k): the regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA's De Novo pathway","volume":"7","author":"Aboy","year":"2024","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.mam.2026.101522_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101522_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11095-024-03664-8","article-title":"PBPK model predictions of disease mediated changes in drug disposition in patients with NAFLD","volume":"41","author":"Adiwidjaja","year":"2024","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.mam.2026.101522_bib5","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1111\/dom.16643","article-title":"Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals. Diabetes","volume":"27","author":"Akinrimisi","year":"2025","journal-title":"Obes. Metabol."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib6","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/biomedicines11113074","article-title":"Allopurinol versus febuxostat: a new approach for the management of hepatic steatosis in metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Al-Shargi","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/tx970139w","article-title":"1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine","volume":"11","author":"Alary","year":"1998","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/biom10111579","article-title":"Acrolein: a potential mediator of oxidative damage in diabetic retinopathy","volume":"10","author":"Alfarhan","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.mam.2026.101522_bib9","article-title":"Evaluation of the relationship between xanthine oxidase activity and metabolic syndrome in a population group in Bangladesh","volume":"14","author":"Ali","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib10","article-title":"AI-powered precision medicine: utilizing genetic risk factor optimization to revolutionize healthcare","volume":"7","author":"Alsaedi","year":"2025","journal-title":"NAR Genom. Bioinf."},{"key":"10.1016\/j.mam.2026.101522_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101899","article-title":"Lipid peroxidation derived reactive carbonyl species in free and conjugated forms as an index of lipid peroxidation: limits and perspectives","volume":"42","author":"Altomare","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.mam.2026.101522_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43066-025-00465-5","article-title":"Preclinical and clinical evidence of xanthine oxidase inhibitors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"15","author":"Alvianto","year":"2025","journal-title":"Egyptian Liver J."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-Omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.mam.2026.101522_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1720780","article-title":"Multiorgan crosstalk in MASLD\/MASH: from hepatic pathogenesis to systemic complications","volume":"16","author":"Bai","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/biology14091140","article-title":"Mitochondrial reverse electron transport: mechanisms, pathophysiological roles, and therapeutic potential","volume":"14","author":"Bao","year":"2025","journal-title":"Biology"},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0026-0495(79)90148-3","article-title":"Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine","volume":"28","author":"Bianchi","year":"1979","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/JP272613","article-title":"Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study","volume":"595","author":"Boets","year":"2017","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib19","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","article-title":"Metabolomic profiles predict individual multidisease outcomes","volume":"28","author":"Buergel","year":"2022","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.mam.2026.101522_bib20","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1016\/j.cell.2024.11.015","article-title":"How to build the virtual cell with artificial intelligence: priorities and opportunities","volume":"187","author":"Bunne","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101522_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/d41586-024-01383-z","article-title":"Major AlphaFold upgrade offers boost for drug discovery","volume":"629","author":"Callaway","year":"2024","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib22","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.7150\/thno.95908","article-title":"Spatial transcriptomics: a powerful tool in disease understanding and drug discovery","volume":"14","author":"Cao","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mam.2026.101522_bib23","article-title":"Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors","volume":"12","author":"Cao","year":"2025","journal-title":"Front. Med."},{"issue":"21","key":"10.1016\/j.mam.2026.101522_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110670","article-title":"Assessment of AOPP, TBARS, and inflammatory status in diabetic nephropathy and hemodialyzed patients","volume":"26","author":"Caragea","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/tx700075y","article-title":"Quantitation of acrolein-derived 3-hydroxypropylmercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry: effects of cigarette smoking","volume":"20","author":"Carmella","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13073-024-01397-2","article-title":"Multiomic integration analysis identifies atherogenic metabolites mediating between novel immune genes and cardiovascular risk","volume":"16","author":"Carreras-Torres","year":"2024","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","article-title":"Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis","volume":"10","author":"Celsa","year":"2025","journal-title":"Lancet. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies","volume":"22","author":"Chan","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol. : Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.mam.2026.101522_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103321","article-title":"Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis","volume":"76","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ptr.70203","article-title":"A novel mechanism of berberine targeting EIF2AK2 dimerization attenuates methylglyoxal-induced endothelial senescence and apoptosis","volume":"40","author":"Chen","year":"2026","journal-title":"Phytother Res. : PTR"},{"key":"10.1016\/j.mam.2026.101522_bib30","first-page":"78","article-title":"AI-driven virtual cell models in preclinical research","volume":"8","author":"Chen","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.mam.2026.101522_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117852","article-title":"Artificial intelligence in metabolomics: a current review","volume":"178","author":"Chi","year":"2024","journal-title":"Trends Anal. Chem. : TRAC"},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"issue":"7087","key":"10.1016\/j.mam.2026.101522_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.mam.2026.101522_bib35","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/nu14224929","article-title":"Association of \u03b1-Dicarbonyls and advanced glycation end products with insulin resistance in non-diabetic young subjects: a case-control study","volume":"14","author":"Csongov\u00e1","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.mam.2026.101522_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70292","article-title":"Entropy and human aging","author":"Cummings","year":"2025","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib37","article-title":"The changing scenario of drug discovery using AI to deep learning","volume":"35","author":"Das","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib38","article-title":"A multimodal deep learning framework for predicting drug\u2013drug interaction events","volume":"40","author":"Deng","year":"2024","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib39","article-title":"Review of AlphaFold 3: transformative advances in drug design and therapeutics","volume":"16","author":"Desai","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.mam.2026.101522_bib40","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/ibd\/izaf231","article-title":"Xanthine oxidase-dependent activation of NLPR3 inflammasome in epithelial cells sustains inflammation in inflammatory bowel disease","volume":"31","author":"Di Petrillo","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.mam.2026.101522_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177840","article-title":"Reduced NF-\u03baB\/NLRP3\/IL-18 signaling increases the protective effect of L-glutamine against LPS-induced retinal inflammation in mice: utilization of network pharmacology and experimental validation","volume":"1002","author":"El Tabaa","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2026.101522_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1455132","article-title":"Serum uric acid and nonalcoholic fatty liver disease","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mam.2026.101522_bib45","article-title":"Trends in AI-based diagnosis and intervention of metabolic diseases: a bibliometric analysis","volume":"12","author":"Fu","year":"2025","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.mam.2026.101522_bib46","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mam.2026.101522_bib47","doi-asserted-by":"crossref","DOI":"10.2196\/66831","article-title":"Applications of AI in predicting drug responses for type 2 diabetes","volume":"10","author":"Garg","year":"2025","journal-title":"JMIR Diabetes"},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13098-025-01796-4","article-title":"CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease","volume":"17","author":"Godoy-Matos","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.mam.2026.101522_bib49","series-title":"Journal of Cheminformatics","article-title":"Proteolysis-targeting Chimera efficacy prediction using a deep-learning-QSP model","author":"Goo","year":"2026"},{"issue":"22","key":"10.1016\/j.mam.2026.101522_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211022","article-title":"Thermodynamic biomarkers of neuroinflammation: nanothermometry, energy-stress dynamics, and predictive entropy in glial-vascular networks","volume":"26","author":"Grigorean","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101522_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s44385-025-00021-1","article-title":"The convergence of AI and synthetic biology: the looming deluge","volume":"2","author":"Groff-Vindman","year":"2025","journal-title":"npj Biomed. Innov."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.mam.2026.101522_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030220","article-title":"Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both","volume":"3","author":"Hayflick","year":"2007","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib55","article-title":"Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"He","year":"2024","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib56","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Hu","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"8","key":"10.1016\/j.mam.2026.101522_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00296-025-05931-2","article-title":"Higher uric acid associated with elevated IL-6 and IL-1\u03b2 levels in older inpatients: a cross-sectional study","volume":"45","author":"Husejko","year":"2025","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib58","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/liv.15596","article-title":"Setanaxib, a first-in-class selective NADPH oxidase 1\/4 inhibitor for primary biliary cholangitis: a randomized, placebo-controlled, phase 2 trial","volume":"43","author":"Invernizzi","year":"2023","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1517\/17425255.2012.695347","article-title":"Role of reactive metabolites in the circulation in extrahepatic toxicity","volume":"8","author":"Irving","year":"2012","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.mam.2026.101522_bib60","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.freeradbiomed.2026.01.004","article-title":"IQ-RKT Formulation mitigates cardiomyocytes injury by targeting AGEs-RAGE-ROS-dependent TRAF3IP2\/JNK apoptotic nexus in diabetes","volume":"246","author":"Jahan","year":"2026","journal-title":"Free Radical Biol. Med."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.medj.2024.07.013","article-title":"Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Jiang","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.mam.2026.101522_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1663094","article-title":"4-HNE-induced cellular dysfunction from lipid peroxidation: a potential therapeutic target in diabetic cardiomyopathy","volume":"13","author":"Jiang","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib63","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3390\/nu17091580","article-title":"Unraveling MASLD: the role of Gut Microbiota, dietary modulation, and AI-Driven Lifestyle Interventions","volume":"17","author":"Jim\u00e9nez-Gonz\u00e1lez","year":"2025","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.mam.2026.101522_bib64","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1038\/psp.2013.41","article-title":"Basic concepts in PBPK modeling in drug discovery and development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.mam.2026.101522_bib65","series-title":"Clinical Pharmacology and Therapeutics","article-title":"Bridging the gap: integrating quantitative systems pharmacology and pharmacometrics in drug development","author":"Kapitanov","year":"2025"},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib66","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.chom.2023.05.011","article-title":"Gut bacterial metabolism contributes to host global purine homeostasis","volume":"31","author":"Kasahara","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mam.2026.101522_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"npj Digit. Med."},{"issue":"13","key":"10.1016\/j.mam.2026.101522_bib68","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib71","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s42255-025-01318-6","article-title":"Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Kim","year":"2025","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib70","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/ijms26031204","article-title":"Advances in the regulation of inflammatory mediators in nitric oxide synthase: implications for disease modulation and therapeutic approaches","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101522_bib72","series-title":"NPJ Systems Biology and Applications","article-title":"Modelling reliable metabolic phenotypes by analysing the context-specific transcriptomics data","author":"Kumar","year":"2025"},{"key":"10.1016\/j.mam.2026.101522_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2025.11.042","article-title":"The AOPP-cNOS relay: a Redox-metabolic pathway in the lung-brain axis of pulmonary hypertension and neurovascular injury","volume":"243","author":"Lee","year":"2026","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.mam.2026.101522_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103807","article-title":"NOX-NOS crosstalk in the liver-brain axis: novel insights for redox regulation and neurodegenerative diseases","volume":"86","author":"Lee","year":"2025","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2011030272","article-title":"Pyridorin in type 2 diabetic nephropathy","volume":"23","author":"Lewis","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib77","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/nu15040832","article-title":"Re-Visiting antioxidant therapy in Murine advanced atherosclerosis with Brussels Chicory, a typical vegetable in Mediterranean diets","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.mam.2026.101522_bib78","series-title":"Acta Pharmaceutica Sinica B","article-title":"Neg-entropy is the true drug target for chronic diseases","author":"Li","year":"2025"},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib76","first-page":"325","article-title":"A review on machine learning principles for multi-view biological data integration","volume":"19","author":"Li","year":"2018","journal-title":"Briefings Bioinf."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-025-02357-x","article-title":"Lipid metabolism in homeostasis and disease","volume":"11","author":"Li","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib80","first-page":"367","article-title":"Gut-liver axis: the role of intestinal microbiota and their metabolites in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Lin","year":"2025","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib84","article-title":"MetaGP: a generative foundation model integrating electronic health records and multimodal imaging for addressing unmet clinical needs","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70042","article-title":"O-GlcNAc transferase promotes metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma by facilitating the degradation of PTEN","volume":"4","author":"Liu","year":"2025","journal-title":"MedComm \u2013 Oncology"},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bpj.2024.02.010","article-title":"An entropy-based approach for assessing the directional persistence of cell migration","volume":"123","author":"Liu","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.mam.2026.101522_bib82","article-title":"Cordycepin attenuates NLRP3\/Caspase-1\/GSDMD-mediated LPS-induced macrophage pyroptosis","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.mam.2026.101522_bib85","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.cmet.2025.10.017","article-title":"Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD","volume":"37","author":"Long","year":"2025","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib86","article-title":"Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD","volume":"7","author":"Longo","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.mam.2026.101522_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122824","article-title":"Liver-based inter-organ communication: a disease perspective","volume":"351","author":"Luo","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.mam.2026.101522_bib88","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.mam.2026.101522_bib89","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10157-015-1207-y","article-title":"Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study","volume":"20","author":"Mafune","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.mam.2026.101522_bib90","article-title":"A Pathophysiology-informed, negentropy-oriented strategy for nanomedicine in MASLD","author":"Mao","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mam.2026.101522_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1297378","article-title":"A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Mart\u00ednez-Sanz","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib92","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-2649-1560","article-title":"Integrated patient digital and biomimetic twins for precision medicine: a perspective","volume":"45","author":"Miedel","year":"2025","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/genes10020087","article-title":"Machine learning and integrative analysis of biomedical big data","volume":"10","author":"Mirza","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.mam.2026.101522_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3085756","article-title":"Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases","volume":"2019","author":"Moldogazieva","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mam.2026.101522_bib95","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-4690-8_2","article-title":"Integrative AI-Based approaches to connect the multiome to use microbiome-metabolome interactive outcome as precision medicine","volume":"2952","author":"Mukhopadhyay","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib96","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-025-59964-z","article-title":"Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk","volume":"16","author":"MULTI consortium","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101522_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1662037","article-title":"Implication of xanthine oxidoreductase in oxidative stress-related chronic diseases","volume":"16","author":"Nelson","year":"2026","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2026.101522_bib98","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41598-020-57784-3","article-title":"Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice","volume":"10","author":"Nishikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101522_bib99","series-title":"Abdominal Radiology","article-title":"Evaluation of liver fibrosis using diffusion-weighted virtual magnetic resonance elastography and ultrasound elastography","author":"Onar","year":"2025"},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5937\/jomb0-53173","article-title":"Paraoxonase-1 activity and AOPP levels in patients with type 2 diabetes mellitus","volume":"45","author":"Ozt\u00fcrk","year":"2026","journal-title":"J. Med. Biochem."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib101","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7150\/thno.111550","article-title":"Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment","volume":"16","author":"Park","year":"2026","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib102","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/nu14030716","article-title":"Simvastatin improves microcirculatory function in nonalcoholic fatty liver disease and downregulates oxidative and ALE-RAGE stress","volume":"14","author":"Pereira","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cels.2021.05.013","article-title":"Schr\u00f6dinger's what is life? At 75","volume":"12","author":"Phillips","year":"2021","journal-title":"Cell Syst."},{"issue":"5","key":"10.1016\/j.mam.2026.101522_bib104","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/tx034185+","article-title":"Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro","volume":"17","author":"Poliakov","year":"2004","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/ATVBAHA.125.322924","article-title":"Lipoprotein(a) and vascular redox state in patients with advanced coronary atherosclerosis","volume":"46","author":"Polkinghorne","year":"2026","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib106","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-024-03301-2","article-title":"Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Pulaski","year":"2025","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib107","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib108","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41467-021-23014-1","article-title":"Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit","volume":"12","author":"Pyrkov","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101522_bib109","doi-asserted-by":"crossref","DOI":"10.37349\/edd.2025.100579","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives","volume":"4","author":"Qian","year":"2025","journal-title":"Exploration of Digestive Diseases"},{"issue":"12","key":"10.1016\/j.mam.2026.101522_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191021","article-title":"Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidation","volume":"135","author":"Queathem","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.mam.2026.101522_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100647","article-title":"Novel eicosanoid signature in plasma provides diagnostic for metabolic dysfunction-associated steatotic liver disease","volume":"65","author":"Quehenberger","year":"2024","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.redox.2013.04.005","article-title":"Sites of reactive oxygen species generation by mitochondria oxidizing different substrates","volume":"1","author":"Quinlan","year":"2013","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10719-021-09980-0","article-title":"Dicarbonyl stress, protein glycation and the unfolded protein response","volume":"38","author":"Rabbani","year":"2021","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13059-025-03886-y","article-title":"A scalable equivariant graph network framework for precise protein function prediction","volume":"26","author":"Ran","year":"2025","journal-title":"Genome Biol."},{"key":"10.1016\/j.mam.2026.101522_bib115","article-title":"Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN\/Arginase\/eNOS uncoupling","volume":"191","author":"Sabry","year":"2025","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.mam.2026.101522_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117527","article-title":"Peroxynitrite is key to cylindrospermopsin-mediated MASLD to MASH progression via triggering TXNIP binding to NLRP3 and subsequent inflammasome activation","volume":"504","author":"Saha","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mam.2026.101522_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.mam.2026.101522_bib118","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.mam.2026.101522_bib119","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/cclm-2012-0878","article-title":"Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen","volume":"52","author":"Scheijen","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib121","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mam.2026.101522_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/417842","article-title":"Reactive carbonyl species in vivo: generation and dual biological effects","volume":"2014","author":"Semchyshyn","year":"2014","journal-title":"Sci. World J."},{"issue":"15","key":"10.1016\/j.mam.2026.101522_bib123","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.7150\/thno.116250","article-title":"Metabolic targeting of oxidative phosphorylation enhances chemosensitivity in triple-negative breast cancer via a synergistic nanomedicine","volume":"15","author":"Shen","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.mam.2026.101522_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107525","article-title":"Role of the ERO1-PDI interaction in oxidative protein folding and disease","volume":"210","author":"Shergalis","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.34172\/mejdd.2025.413","article-title":"Extrahepatic comorbidities associated with metabolic dysfunction-associated steatotic liver disease; A tertiary hospital experience","volume":"17","author":"Sohrabi","year":"2025","journal-title":"Middle East J. Digestive Dis."},{"key":"10.1016\/j.mam.2026.101522_bib126","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinf. Biol. Insights"},{"issue":"10","key":"10.1016\/j.mam.2026.101522_bib127","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxaf233","article-title":"Exploring the therapeutic role of probiotics and prebiotics in mitigating diseases associated with advanced glycation end products","volume":"136","author":"Sun","year":"2025","journal-title":"J. Appl. Microbiol."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mam.2026.101522_bib129","article-title":"Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD","volume":"10","author":"Svensson","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2026.101522_bib130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jnutbio.2017.02.010","article-title":"The metabolic fate of isotopically labeled trimethylamine-N-oxide (TMAO) in humans","volume":"45","author":"Taesuwan","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"17","key":"10.1016\/j.mam.2026.101522_bib131","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib132","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","article-title":"Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases","volume":"81","author":"Thiele","year":"2024","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.mam.2026.101522_bib133","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.mam.2026.101522_bib134","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1109\/RBME.2023.3324264","article-title":"Integrating multi-omics data with EHR for precision medicine using advanced artificial intelligence","volume":"17","author":"Tong","year":"2024","journal-title":"IEEE Rev. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.mam.2026.101522_bib136","article-title":"A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout","volume":"458","author":"Ullah","year":"2024","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.mam.2026.101522_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103825","article-title":"Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities","volume":"29","author":"Ung","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.mam.2026.101522_bib138","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.clnu.2021.03.042","article-title":"Diet-induced weight loss reduces postprandial dicarbonyl stress in abdominally obese men: secondary analysis of a randomized controlled trial","volume":"40","author":"Van den Eynde","year":"2021","journal-title":"Clin. Nutr. (Edinburgh, Scotland)"},{"issue":"21","key":"10.1016\/j.mam.2026.101522_bib139","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2317616121","article-title":"Lipid-derived electrophiles inhibit the function of membrane channels during ferroptosis","volume":"121","author":"Van Kessel","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib140","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1021\/pr1000576","article-title":"A metabolic entropy approach for measurements of systemic metabolic disruptions in patho-physiological States","volume":"9","author":"Veselkov","year":"2010","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.mam.2026.101522_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009294","article-title":"A pipeline for the reconstruction and evaluation of context-specific human metabolic models at a large-scale","volume":"18","author":"Vieira","year":"2022","journal-title":"PLoS Comput. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2026.101522_bib142","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.mam.2026.101522_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123211","article-title":"Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"359","author":"Wang","year":"2024","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib144","first-page":"2089","article-title":"Machine learning empowering drug discovery: applications, opportunities and challenges","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.mam.2026.101522_bib145","article-title":"Dietary pattern modifies the risk of MASLD through metabolomic signature","volume":"6","author":"Wu","year":"2024","journal-title":"JHEP Rep.: innov. Hepatol."},{"key":"10.1016\/j.mam.2026.101522_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106038","article-title":"The role of circulating metabolomics in linking metabolic dysfunction, inflammation, and risk of diverticulitis outcomes","volume":"122","author":"Wu","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mam.2026.101522_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1553722","article-title":"Single-cell sequencing and spatial transcriptomics reveal the evolution of glucose metabolism in hepatocellular carcinoma and identify G6PD as a potential therapeutic target","volume":"15","author":"Xi","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2026.101522_bib149","article-title":"Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathway","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mam.2026.101522_bib148","first-page":"489","article-title":"NAFLDsym: a quantitative systems pharmacology model for NAFLD progression","volume":"115","author":"Yang","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mam.2026.101522_bib150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ab.2018.11.007","article-title":"Simplified LC\/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples","volume":"566","author":"Yermalitsky","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mam.2026.101522_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/qub2.70002","article-title":"Revolutionizing multi-omics analysis with artificial intelligence and data processing","author":"Yetgin","year":"2025","journal-title":"Quantit. Biol."},{"issue":"8","key":"10.1016\/j.mam.2026.101522_bib152","article-title":"2-Hydroxybenzylamine for treatment of atrial fibrillation: a first-in-human clinical pilot trial","volume":"18","author":"Yoneda","year":"2025","journal-title":"Circulation: Arrhythmia Electrophysiol."},{"key":"10.1016\/j.mam.2026.101522_bib153","article-title":"Metabolomic aging clock predicts risk of different cardiovascular diseases in the UK Biobank","author":"You","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.mam.2026.101522_bib154","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","author":"Yu","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.mam.2026.101522_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100783","article-title":"Integrating gut microbiome and metabolome to gain insight into metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Zhang","year":"2025","journal-title":"Gastro Hep Adv."},{"issue":"7","key":"10.1016\/j.mam.2026.101522_bib156","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000484","article-title":"Gut microbial metabolites in MASLD: implications of mitochondrial dysfunction in the pathogenesis and treatment","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"5","key":"10.1016\/j.mam.2026.101522_bib155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.mam.2026.101522_bib158","article-title":"Evaluation of the PK\/PD changes on MASLD-related population","volume":"14","author":"Zhao","year":"2025","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"4","key":"10.1016\/j.mam.2026.101522_bib159","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.mam.2026.101522_bib160","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202101107","article-title":"Metabolic investigation on the interaction mechanism between dietary Dihydrochalcone intake and lipid peroxidation product Acrolein reduction","volume":"66","author":"Zhu","year":"2022","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:28:56Z","timestamp":1792708136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299726000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":160,"alternative-id":["S0098299726000786"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2026.101522","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermediate-half-life metabolites as systemic relay nodes in metabolic disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2026.101522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101522"}}